0 NYSE Companies - February 4, 2019Whitestone REIT Announces Fourth Quarter 2018 Earnings Webcast and Conference CallHOUSTON, Feb. 04, 2019 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that it will release […]Read More
0 TSX Venture News - February 4, 2019dynaCERT Launches HydraGEN™ Technology for the Mining IndustryTORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) — dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) (“dynaCERT” or the “Company”) […]Read More
0 TSX Venture News - February 4, 2019Radient Technologies Inc. Announces Changes to its Board of Directors and Provides Corporate UpdateEDMONTON, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) […]Read More
0 TSX Venture News - February 4, 2019Radient Technologies Inc. Receives Standard Processing License from Health CanadaEDMONTON, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) […]Read More
0 TSX Venture News - February 4, 2019Canopy Rivers Announces Completion of $17 Million Financing for Its Italian Hemp Platform – CanaparTORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) — Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV: RIV) is pleased to […]Read More
0 NASDAQ Companies - February 4, 2019uniQure Announces First Patient Treated in HOPE-B Pivotal Trial of AMT-061 in Patients with Hemophilia BFull Patient Enrollment in Study Expected by Year-End 2019 LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Feb. 04, 2019 (GLOBE NEWSWIRE) […]Read More
0 NASDAQ Companies - February 4, 2019Anavex Life Sciences to Present at the 2019 BIO CEO & Investor ConferenceNEW YORK, Feb. 04, 2019 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]Read More
0 NASDAQ Companies - February 4, 2019Spero Therapeutics Announces FDA Acceptance of IND Application for SPR994CAMBRIDGE, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing […]Read More
0 NASDAQ Companies - February 4, 2019Athenex Announces Late-Breaking Oral Presentation of KX2-391 Ointment in Two Phase III Studies at the American Academy of Dermatology Annual MeetingResults from Phase III pivotal studies to be featured at Late-Breaking Research Program on March 2, 2019 BUFFALO, N.Y., Feb. […]Read More
0 NASDAQ Companies - February 4, 2019DSP Group, Inc. Reports Fourth Quarter 2018 and Full Year ResultsGrowth Initiatives Account for a Majority of Annual Revenues for the First Time Annual Gross Margins at All-Time High of […]Read More